Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,768 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00626561 | Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2014 | clinicaltrials |
| NCT00515073 | Papillary Serous Carcinoma of the Endometrium | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 3, 2014 | clinicaltrials |
| NCT00415909 |
| TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients |
| terminated |
| Phase 2 |
| 3 |
| M.D. Anderson Cancer CenterOTHER |
| 1 |
| Jun 30, 2014 |
| clinicaltrials |
| NCT01417065 | Temsirolimus In Phase 0 | completed | Early Phase 1 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT01139151 | 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies | completed | Phase 1 | 31 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00947648 | Outpatient Neutropenic Diet Study | terminated | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT00941928 | Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00495235 | Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas | completed | — | 147 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT01030497 | Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System | completed | — | 1 | M.D. Anderson Cancer CenterOTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT00147225 | AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | completed | Phase 1 / Phase 2 | 55 | M.D. Anderson Cancer CenterOTHER | 1 | May 8, 2014 | clinicaltrials |
| NCT01542684 | Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) | terminated | Phase 2 | 8 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 30, 2014 | clinicaltrials |
| NCT02044601 | Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT00112996 | Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 244 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT00866346 | PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 4, 2014 | clinicaltrials |
| NCT02029612 | An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy) | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 28, 2014 | clinicaltrials |
| NCT02028039 | IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00657371 | Efficacy of the Third Eye Retroscope Auxiliary Imaging System | completed | N/A | 288 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 9, 2013 | clinicaltrials |
| NCT00472849 | Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias | completed | Phase 1 / Phase 2 | 92 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT00968838 | A Study for Leukemia Patients With Life-Threatening Infections | completed | Phase 3 | 178 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT00387023 | Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma | completed | N/A | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2013 | clinicaltrials |
| NCT00500565 | Pain Management Following TRAM Flap for Breast Reconstruction | completed | N/A | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00882102 | Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS) | completed | Phase 2 | 43 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00539227 | A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy | completed | — | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00510653 | Gleevec Study for Patients With Ovarian Cancer | completed | Phase 2 | 73 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00360672 | Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome | completed | Phase 2 | 27 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 14, 2013 | clinicaltrials |
| NCT01518140 | BiPAP-Vapotherm RCT | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 13, 2013 | clinicaltrials |
| NCT00499343 | G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients | completed | Phase 2 | 84 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01200004 | Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide | terminated | Phase 1 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00628628 | Rasburicase in Patients at Risk for Tumor Lysis Syndrome | completed | Phase 2 | 82 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2013 | clinicaltrials |
| NCT00607113 | Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 2 | 41 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00504504 | Rituximab and ABVD for Hodgkin's Patients | completed | Phase 2 | 85 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00352846 | Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss | completed | Phase 3 | 135 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00651755 | Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients | completed | N/A | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01412749 | TEST: Registry for Endoscopic Head and Neck Surgery(TEST) | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00488644 | Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors | terminated | N/A | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00907192 | Self Reported Deviations From Opioid Analgesic Prescription | completed | — | 201 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00048737 | Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies | completed | Phase 1 / Phase 2 | 70 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 13, 2013 | clinicaltrials |
| NCT01024166 | Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study | completed | — | 18 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 7, 2013 | clinicaltrials |
| NCT00493454 | Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas | terminated | Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | May 31, 2013 | clinicaltrials |
| NCT01031602 | Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients | completed | — | 160 | M.D. Anderson Cancer CenterOTHER | 1 | May 29, 2013 | clinicaltrials |
| NCT00583622 | Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients | terminated | Phase 2 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00963859 | Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder | completed | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00242502 | Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery | completed | Phase 2 | 62 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT00491075 | Pemetrexed Plus Gemcitabine in Renal Cell Cancer | terminated | Phase 2 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00968461 | Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 15, 2013 | clinicaltrials |
| NCT00429182 | Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | completed | Phase 2 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00525980 | Cancer Genetics CD-ROM for Hispanics | completed | N/A | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01432119 | Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 9, 2013 | clinicaltrials |
| NCT00301028 | Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer | completed | Phase 2 | 48 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials